<DOC>
<DOCNO>EP-0646596</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Nucleic acid binding oligomers having C-branches for therapy and diagnosis
</INVENTION-TITLE>
<CLASSIFICATIONS>C07K500	A61K3140	A61K31505	C07K5117	C07D23900	C07D47330	C07C30966	A61K3140	A61P3112	C07D47334	C07C27100	C07K5062	A61K3800	C07C27122	C07K5078	C07C30900	C07D47318	A61K3800	C12N1509	C12N1509	C07D20716	A61K31505	C07K700	C07D40300	C07D20700	C07D47300	C07D40304	C07D23954	C07D40312	C07K708	A61P3100	C07K5097	C07D23946	C07K1400	A61K31495	C07K1400	C07D23947	A61K31495	C07K706	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07K	A61K	A61K	C07K	C07D	C07D	C07C	A61K	A61P	C07D	C07C	C07K	A61K	C07C	C07K	C07C	C07D	A61K	C12N	C12N	C07D	A61K	C07K	C07D	C07D	C07D	C07D	C07D	C07D	C07K	A61P	C07K	C07D	C07K	A61K	C07K	C07D	A61K	C07K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07K5	A61K31	A61K31	C07K5	C07D239	C07D473	C07C309	A61K31	A61P31	C07D473	C07C271	C07K5	A61K38	C07C271	C07K5	C07C309	C07D473	A61K38	C12N15	C12N15	C07D207	A61K31	C07K7	C07D403	C07D207	C07D473	C07D403	C07D239	C07D403	C07K7	A61P31	C07K5	C07D239	C07K14	A61K31	C07K14	C07D239	A61K31	C07K7	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to nucleic acid-binding oligomers with C branching of the general formula (I) 
<
IMAGE
>
 and to the corresponding monomers, whose radicals have the meaning stated in the description, to the use thereof as pharmaceuticals or as diagnostic aids.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Compounds of the general formula (I)


in which

A
represents -CO-, -CHR- or -CRR'-,
B
independently of one another is selected from
a group consisting of:

(C
1
-C
4
)-alkanoyl, DNA intercalators, aromatic
radicals, heterocyclic radicals, naturally

occurring nucleic bases, such as thymine,
uracil, cytosine, adenine, guanine, hypoxanthine,

inosine or substances derived from these
by chemical modification, and halogenated

precursors of these nucleic bases, and protected
derivatives of the nucleic bases having

the protective groups which are customary in 
nucleotide or peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NH-, -NR-, -CHR-, -CRR'-, -O- or
-S-,

A and E can be linked to each other via an alkyl
chain [-(CH
2
)
n
- where n = 1, 2],


F
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example:

glycine, alanine, valine, leucine, isoleucine,
serine, threonine, cysteine, methionine,

phenylalanine, tyrosine, histidine, tryptophan,
lysine, ornithine, aspartic acid, glutamic

acid, asparagine, glutamine, arginine, proline,
hydroxyproline, sarcosine, aminoisobutyric

acid, dehydroamino acids, such as, for example,
dehydroalanine, dehydro-α-aminobutyric acid,

other unnatural amino acids, such as
phenylglycine, 4-nitrophenylalanine, 3-nitrophenylalanine,

2-nitrophenylalanine, 2-, 3- or
4-aminophenylalanine, 3,4-dichlorophenylalanine,

4-iodophenylalanine, 4-methoxyphenylalanine,
1-triazolylalanine, 2-pyridylalanine,

3-pyridylalanine, 4-pyridylalanine, 1-naphthylalanine
or 2-naphthylalanine, if appropriate

having protective groups, where Q stereochemically
uniformly exists in the L form or the D 

form,

G and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


G
represents -NH-, -NR-, -O- or -S-,
M
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
K
represents carrier system, reporter ligand, H
or solubilizing group,
N
represents carrier system, reporter ligand, OH
or solubilizing group,
s
represents a value from 1 to 30 and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the general formula (I) according to
Claim 1, in which


A
represents -CO-, -CHR- or -CRR'-,
B
independently of one another is selected from
a group consisting of:

(C
1
-C
4
)-alkanoyl, DNA intercalators, aromatic
radicals, heterocyclic radicals, naturally

occurring nucleic bases, such as thymine,
uracil, cytosine, adenine, guanine, hypoxanthine,

inosine and halogenated precursors of
these nucleic bases, and protected derivatives

of the nucleic bases having the protective
groups which are customary in nucleotide or

peptide chemistry, 
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NR-, -NH-, -CHR-, -CRR'- or -O-,

A and E can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


F
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example:

glycine, alanine, valine, leucine, isoleucine,
serine, threonine, cysteine, methionine,

phenylalanine, tyrosine, histidine, tryptophan,
lysine, ornithine, aspartic acid, glutamic

acid, asparagine, glutamine, arginine, proline,
hydroxyproline, sarcosine, aminoisobutyric

acid, dehydroamino acids, such as, for example,
dehydroalanine, dehydro-a-aminobutyric acid,

other unnatural amino acids, such as phenylglycine,
4-nitrophenylalanine, 3-nitrophenylalanine,

2-nitrophenylalanine, 1 -naphthylalanine
or 2-naphthylalanine, if appropriate

having protective groups, where Q stereochemically
uniformly exists in the L form or the D

form,

G and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


G
represents -NH-, -NR- or -O-, 
M
represents -CH
2
-, -CO-, -SO
2
- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
K
represents carrier system, reporter ligand, H
or solubilizing group,
N
represents carrier system, reporter ligand, OH
or solubilizing group,
s
represents a value from 1 to 30 and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the general formula (I) according to
Claim 1, in which


A
represents -CO-, -CHR- or -CRR'-,
B
independently of one another is selected from
a group consisting of:

(C
1
-C
4
)-alkanoyl, DNA intercalators, aromatic
radicals, heterocyclic radicals, naturally

occurring nucleic bases, such as thymine,
uracil, cytosine, adenine, guanine, hypoxanthine,

inosine and halogenated precursors of
these nucleic bases, and protected derivatives

of the nucleic bases having the protective
groups which are customary in nucleotide or

peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NR-, -NH- or -CHR-,
 
A and E can be linked to each other via an alkyl

chain [(-CH
2
)
n
- where n = 1, 2],


F represents -CH
2
-, -CO- or -CS-,
Q represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example:

glycine, alanine, valine, leucine, isoleucine,
serine, threonine, cysteine, methionine,

phenylalanine, tyrosine, histidine, tryptophan,
lysine, ornithine, aspartic acid, glutamic

acid, asparagine, glutamine, arginine, proline,
hydroxyproline, sarcosine, aminoisobutyric

acid, dehydroamino acids, such as, for example,
dehydroalanine, dehydro-a-aminobutyric acid,

other unnatural amino acids, such as phenylglycine,
if appropriate having protective

groups, where L stereochemically uniformly
exists in the L form or the D form,

G and Q can be linked to each other via an alkyl

chain [(-CH
2
)
n
- where n = 1, 2],


G
represents -NH-, -NR- or -O-,
M
represents -CH
2
-, -CO- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
K
represents carrier system, reporter ligand, H
or solubilizing group,
N
represents carrier system, reporter ligand, OH
or solubilizing group, 
s
represents a value from 1 to 30 and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the general formula (II)


in which

A represents -CO-, -CHR- or -CRR'-,
B
independently of one another is selected from
a group consisting of: (C
1
-C
4
)-alkanoyl, DNA
intercalators, aromatic radicals, heterocyclic

radicals, naturally occurring nucleic bases,
such as thymine, uracil, cytosine, adenine,

guanine, hypoxanthine, inosine or derivatives
obtained from these by chemical modification,

and halogenated precursors of these nucleic
bases, and protected derivatives of these

nucleic bases having the protective groups
which are customary in nucleotide or peptide

chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NH-, -NR-, -CHR-, -CRR'-, -O- or
-S-, 
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid,
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, 4-nitrophenylalanine, 3-nitrophenylalanine,
2-nitrophenylalanine, 2-, 3- or

4-aminophenylalanine, 3,4-dichlorophenylalanine,
4-iodophenylalanine, 4-methoxyphenylalanine,

1-triazolylalanine, 2-pyridylalanine,
3-pyridylalanine, 4-pyridylalanine, 1-naphthylalanine

or 2-naphthylalanine, if appropriate
having protective groups, where Q stereochemically

uniformly exists in the L form or the D
form,

E and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


M
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected
form, 
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group,
and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the formula (II) according to Claim 4,
in which


A
represents -CO-, -CHR- or -CRR'-,
B
independently of one another is selected from
a group consisting of: (C
1
-C
4
)-alkanoyl, DNA
intercalators, aromatic radicals, heterocyclic

radicals, naturally occurring nucleic bases,
such as thymine, uracil, cytosine, adenine,

guanine, hypoxanthine, inosine and halogenated
precursors of these nucleic bases, and protected

derivatives of these nucleic bases
having the protective groups which are customary

in nucleotide or peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NR-, -NH-, -CHR-, -CRR'- or -O-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid, 
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, 4-nitrophenylalanine, 3-nitrophenylalanine,
2-nitrophenylalanine, 1-naphthylalanine

or 2-naphthylalanine, if appropriate
having protective groups, where Q

stereochemically uniformly exists in the L form
or the D form,

E and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n =1, 2],


M
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected
form,
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group,
and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the general formula (II) according to
Claim 4, in which


A
represents -CO-, -CHR- or -CRR'-, 
B
independently of one another is selected from
a group consisting of: (C
1
-C
4
)-alkanoyl, DNA
intercalators, aromatic radicals, heterocyclic

radicals, naturally occurring nucleic bases,
such as thymine, uracil, cytosine, adenine,

guanine, hypoxanthine, inosine and halogenated
precursors of these nucleic bases, and protected

derivatives of these nucleic bases
having the protective groups which are customary

in nucleotide or peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
D
represents -NH-, -CH
2
-, -CHR- or -CRR'-,
E
represents -NR-, -NH-, -CHR- or -O-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid,
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, if appropriate having protective
groups, where Q stereochemically uniformly

exists in the L form or the D form,

E and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2], 


M
represents -CH
2
-, -CO- or -CS-,
L
represents (CH
2
)
p
 where p = 0, 1, 2, -CHR- or
-CRR'-,
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected form
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group
and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the general formula (III)


in which

B
independently of one another is selected from
a group consisting of: (C
1
-C
4
)-alkanoyl, DNA
intercalators, aromatic radicals, heterocyclic

radicals, naturally occurring nucleic bases,
such as thymine, uracil, cytosine, adenine,

guanine, hypoxanthine, inosine or derivatives
obtained from these by chemical modification,

and halogenated precursors of these nucleic
bases, and protected derivatives of these

nucleic bases having the protective groups 
which are customary in nucleotide or peptide

chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
E
represents -NR-, -CHR-, -CRR'-, -O- or -S-,
Q
represents (-CR
1
R
2
-)
m
, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid,
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, 4-nitrophenylalanine, 3-nitrophenylalanine,
2-nitrophenylalanine, 2-, 3- or

4-aminophenylalanine, 3,4-dichlorophenylalanine,
4-iodophenylalanine, 4-methoxyphenylalanine,

1-triazolylalanine, 2-pyridylalanine,
3-pyridylalanine, 4-pyridylalanine, 1-naphthylalanine

or 2-naphthylalanine, if appropriate
having protective groups, where Q stereochemically

uniformly exists in the L form or the D
form,

E and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


M
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
L
represents CH
2
, 
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected
form,
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group,
W
represents a chiral C atom which can uniformly
exist in the S or R configuration and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the formula (III) according to Claim 7,
in which


B
independently of one another is selected from
a group consisting of: -H, -OH, (C
1
-C
4
)-alkanoyl,
DNA intercalators, aromatic radicals,

heterocyclic radicals, naturally occurring
nucleic bases, such as thymine, uracil,

cytosine, adenine, guanine, hypoxanthine,
inosine and halogenated precursors of these

nucleic bases, and protected derivatives of
these nucleic bases having the protective

groups which are customary in nucleotide or
peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
E
represents -NR-, -NH-, -CHR-, -CRR'- or -O-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are 
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid,
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, 4-nitrophenylalanine, 3-nitrophenylalanine,
2-nitrophenylalanine, 1-naphthylalanine

or 2-naphthylalanine, if appropriate
having protective groups, where Q

stereochemically uniformly exists in the L form
or the D form,

E and Q can be linked to each other via an alkyl
chain [(-CH
2
)
n
- where n = 1, 2],


M
represents -CH
2
-, -CO-, -SO
2
-, -SO- or -CS-,
L
represents -CH
2
-,
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected
form,
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group,
W
represents a chiral C atom which can uniformly
exist in the S or R configuration, and
 
R and R' represent H, OH, alkyl, aralkyl or aryl.
Compounds of the formula (III) according to Claim 7,
in which


B
independently of one another is selected from
a group consisting of: -H, -OH, (C
1
-C
4
)-alkanoyl,
DNA intercalators, aromatic radicals,

heterocyclic radicals, naturally occurring
nucleic bases, such as thymine, uracil,

cytosine, adenine, guanine, hypoxanthine,
inosine and halogenated precursors of these

nucleic bases, and protected derivatives of
these nucleic bases having the protective

groups which are customary in nucleotide or
peptide chemistry,
C
represents -CH- or -CR-, where C can uniformly
exist in the S or R configuration,
E
represents -NR-, -NHR-, -CHR- or -O-,
Q
represents (-CR
1
R
2
)
m
-, where m is 0, 1 or 2 and
R
1
 and R
2
 independently of one another are
selected from a group consisting of radicals of

natural or unnatural amino acids, such as, for
example: glycine, alanine, valine, leucine,

isoleucine, serine, threonine, cysteine,
methionine, phenylalanine, tyrosine, histidine,

tryptophan, lysine, ornithine, aspartic acid,
glutamic acid, asparagine, glutamine, arginine,

proline, hydroxyproline, sarcosine, aminoisobutyric
acid, dehydroamino acids, such as, for

example, dehydroalanine, dehydro-α-aminobutyric
acid, other unnatural amino acids, such as

phenylglycine, if appropriate having protective
groups, where Q stereochemically uniformly

exists in the L form or the D form, 
E and Q can be linked to each other via an alkyl

chain [(-CH
2
)
n
- where n = 1, 2],
M
represents -CH
2
-, -CO- or -CS-,
L
represents -CH
2
-,
U
represents -NH- or -NR-,
X
represents any protective group known from
peptide chemistry, H or any natural or unnatural

amino acid in protected or unprotected
form,
Y
represents COOH, CSOH, CH
2
OH or COOR" where R"
is any protective group from peptide chemistry,

carrier, reporter ligand or solubilizing group,
W
represents a chiral C atom which can uniformly
exist in the S or R configuration and

R and R' represent H, OH, alkyl, aralkyl or aryl.
Medicaments containing one or more compounds of
Claims 1 to 9.
</CLAIMS>
</TEXT>
</DOC>
